Johnson & Johnson’s Janssen unit was hit with an $8 billion punitive-damages verdict -- the largest jury award in the U.S. this year -- over its alleged mishandling of an anti-psychotic drug blamed for causing adolescent boys to grow female-sized breasts.
A state court jury in Philadelphia Tuesday concluded the Janssen’s wrongful marketing of its Risperdal drug to teens warranted the punishment award in the first Pennsylvania case in which such damages could be awarded under an appellate ruling.
